Oncoceutics Receives Foundation Grants to Establish an Expanded Access
09 Nov 2020 //
PRESS RELEASE
Oncoceutics Begins Trial with Next-Generation Imipridone ONC206
28 Oct 2020 //
PRESS RELEASE
Oncoceutics Expands IP Portfolio With Additional Patents for ONC201 and ONC212
13 Oct 2020 //
PRESS RELEASE
Oncoceutics to Present Additional Data at ASCO Showing Clinical Benefit ONC201
30 May 2020 //
ONCOCEUTICS
Phase I/II Clinical Study of ONC201 Begins in Japan
01 Apr 2020 //
ONCOCEUTICS